Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/2 clinical trial evaluating a vaccine therapy for stage III or stage IV melanoma that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University Hospital Erlangen | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED